Clinical Trials Logo

PVI clinical trials

View clinical trials related to PVI.

Filter by:
  • None
  • Page 1

NCT ID: NCT05486364 Completed - Atrial Fibrillation Clinical Trials

DIGITal mOnitoring afTer Af abLation

DIGITOTAL
Start date: December 20, 2021
Phase: N/A
Study type: Interventional

Recurrence of atrial fibrillation (AF) after a pulmonary vein isolation (PVI) procedure is frequent. Current follow up with Holter monitoring and electrocardiograms (ECG) during outpatient clinic consultations cover only short time stretches and require hospital visits. Mobile health solutions with rhythm monitoring using photoplethysmography (PPG) technology on a smartphone could extend rhythm monitoring time, while lowering hospital visits and cost. This study aims to compare the performance of a digital health solution using PPG technology on a smartphone versus the current standard of care to monitor for AF recurrence after a PVI procedure.

NCT ID: NCT05273645 Not yet recruiting - Atrial Fibrillation Clinical Trials

PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study

POTTER
Start date: March 31, 2022
Phase:
Study type: Observational

Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation procedure. This complication (0.016-0.07%) requires an international effort to allow for better understanding of the factors contributing to its occurrence and the best management strategies. A worldwide, retrospective, multicenter registry focusing on the incidence, diagnosis and management of this complication.

NCT ID: NCT04835610 Completed - PVI Clinical Trials

Effectiveness of Finger and Forehead Plethysmographic Variability Index Monitoring in Pediatric Patients

Start date: January 20, 2020
Phase:
Study type: Observational [Patient Registry]

In pediatric surgical patients, the sensitivity of forehead and finger PVI monitoring was similar for the prediction of fluid responsiveness, whereas the specificity of forehead monitoring was higher. The use of forehead PVI probes in the fluid management of these patients seemed to be appropriate because cephalic region was not affected by low perfusion states.